Abstract:BACKGROUND CONTEXT As lateral lumbar interbody fusions (LLIF) are increasingly performed, our understanding of postoperative clinical trajectories are important in informing preoperative patient expectations. While minimum clinically important difference (MCID) rates are widely utilized in spine surgery literature, there is less published on how long it takes for patients to achieve MCID following LLIF. PURPOSE The purpose of this study is to evaluate the length of time it takes for patients to report MCID achievement for back pain, leg pain, disability, and physical function and evaluate predictors of time to achieve MCID. STUDY DESIGN/SETTING This is a retrospective review. PATIENT SAMPLE Patients undergoing elective LLIF with baseline and postoperative patient-reported outcomes reported. OUTCOME MEASURES Oswestry Disability Index (ODI), VAS-Back, VAS-Leg, and Patient-Reported Outcome Measurement Information System-Physical Function (PROMIS-PF) METHODS Patients undergoing elective LLIF by the senior author with baseline and postoperative PROs recorded were retrospectively identified. Data on potential predictors of time to MCID achievement were gathered including demographics, comorbidities, diagnostic information, and baseline patient-reported outcomes (PROs). MCID achievement rates for Oswestry Disability Index (ODI), Visual Analog Scale-Back (VAS-Back), VAS-Leg, and Patient-Reported Outcome Measurement Information System-Physical Function (PROMIS-PF) were calculated at six-, twelve, 6 month- 1 year- and 2-year postoperative timepoints. A Kaplan-Meier survival analysis was conducted to determine the proportion of patients achieving MCID at each timepoint. A multivariate Cox regression determined predictors of time to MCID achievement. RESULTS One hundred and five patients were included in the analysis. The mean time to achieve MCID for PROMIS-PF was 44.7 weeks, for VAS-Back was 38.5 weeks, for VAS-Leg was 36.7 weeks and for ODI was 38.3 weeks. Worse baseline VAS-Back significantly predicted for earlier MCID achievement for VAS-Back (HR: 1.55), while diabetes was predictive of later MCID achievement (HR: 0.21). Higher body mass index and worse preoperative ODI predicted earlier MCID achievement for ODI (HR: 1.04-1.08), and higher VAS-Leg score, and two-level fusion were predictive of later MCID achievement for ODI, (HR:0.26-0.81). Worse preoperative VAS-Leg, isthmic spondylolisthesis, and three-level fusion were predictors of earlier achievement of MCID for VAS-Leg (HR: 1.27-6.47). Herniated nucleus pulposus and foraminal stenosis were early predictors (HR: 2.92-3.23) and workers' compensation was a late predictor of MCID attainment for PROMIS-PF (HR: 0.13). CONCLUSIONS Select demographic variables, comorbidities, spinal pathology, and preoperative PROs influenced the time it took for patients to report clinically significant improvements in pain, disability, and physical function scores. These findings can be used to prognosticate outcomes for patients undergoing LLIF and inform patient expectations of postoperative recovery. FDA Device/Drug Status This abstract does not discuss or include any applicable devices or drugs.

Prognosis of Symptomatic Pseudarthrosis Observed at 1 Year After Lateral Lumbar Interbody Fusion

Incidence Et Facteurs De Risque De La Migration Des Cages Latérales Après Le Premier Temps D’arthrodèse Intersomatique Antéro-Latérale Circonférentielle

Pseudarthrosis risk factors in lumbar fusion: a systematic review and meta-analysis

Development and Validation of a Risk Prediction Model for Pseudarthrosis Following Transforaminal Lumbar Interbody Fusion: A Retrospective Analysis

Pseudarthrosis in adult and pediatric spinal deformity surgery: a systematic review of the literature and meta-analysis of incidence, characteristics, and risk factors

The Effects of Preoperative Epidural Steroid Injection on Pseudarthrosis Following Lumbar Fusion

Prolonged length of stay and discharge disposition to rehabilitation facilities following single-level posterior lumbar interbody fusion for acquired spondylolisthesis

Sarcopenia Predicts the Development of Early Adjacent Segment Disease After Transforaminal Lumbar Interbody Fusion

Predictors of time to achieve clinically significant improvements following lateral lumbar interbody fusion

P282. Predictors of time to achieve clinically significant improvements following lateral lumbar interbody fusion

Adjacent segment degeneration at a minimum 2-year follow-up after posterior lumbar interbody fusion: the impact of sagittal spinal proportion: a retrospective case series

Clinical observation of pseudarthrosis after anterior cervical fusion

Incidence and Risk Factors of Lumbosacral Complications Following Long‐Segment Spinal Fusion in Adult Degenerative Scoliosis

L5-S1 Transforaminal Lumbar Interbody Fusion (TLIF) Is Associated with Increased Revisions Compared to L4-L5 TLIF at Two Years

Diagnosis and surgical treatment of the pseudarthrosis after lumbar spinal fusion

Risk factors for adjacent segment disease requiring reoperation after posterior lumbar interbody fusion with screw fixation: focus on paraspinal muscle, facet joint, and disc degeneration

Contribution of MRI and Imaging Exams in the Diagnosis of Lumbar Pseudarthrosis

Pseudarthrosis in multilevel anterior cervical fusion with rhBMP-2 and allograft: analysis of one hundred twenty-seven cases with minimum two-year follow-up.

Pelvic Incidence–Lumbar Lordosis Mismatch Is Predisposed to Adjacent Segment Degeneration After Single-Level Anterior Lumbar Interbody Fusion: A Retrospective Case-Control Study

Preoperative Symptom Duration and the Effect on Clinical Outcomes and PROMIS-PF in Patients Undergoing Lumbar Fusion Surgery

Retrospective analysis of medium-term outcomes following anterior lumbar interbody fusion surgery performed in a tertiary spinal surgical centre